Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
iRhythm Holdings's operating assets for the quarter that ended in Mar. 2026 was $456.7 Mil. iRhythm Holdings's operating liabilities for the quarter that ended in Mar. 2026 was $115.9 Mil. iRhythm Holdings's Total Assets for the quarter that ended in Dec. 2025 was $1,020.0 Mil. Therefore, iRhythm Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.33.
iRhythm Holdings Scaled Net Operating Assets Related Terms
iRhythm Holdings Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for iRhythm Holdings's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Holdings Scaled Net Operating Assets Chart
LTS:0A7L vs HAE, LIVN, ITGR: Scaled Net Operating Assets Comparison
For the Medical Devices subindustry, iRhythm Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Holdings Scaled Net Operating Assets vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where iRhythm Holdings's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.33 mean?
iRhythm Holdings (LTS:0A7L) has a Scaled Net Operating Assets of 0.33 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on iRhythm Holdings and its competitors.
Is iRhythm Holdings' Scaled Net Operating Assets too high?
iRhythm Holdings' current Scaled Net Operating Assets is 0.33. Overall, iRhythm Holdings has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Scaled Net Operating Assets compare to HAE and LIVN?
iRhythm Holdings' Scaled Net Operating Assets of 0.33 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on iRhythm Holdings and its competitors. iRhythm Holdings's current Scaled Net Operating Assets is 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (LTS:0A7L) is currently considered Significantly Undervalued. The stock's GF Value™ is $163.77, compared to a current price of $115.18 — trading 29.7% below its estimated fair value. The current Scaled Net Operating Assets is 0.33. iRhythm Holdings' overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For iRhythm Holdings (LTS:0A7L), the current Scaled Net Operating Assets is 0.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRhythm Holdings (LTS:0A7L) Overvalued in 2026?
Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued.
The current stock price of $115.18 is trading 29.7% below its estimated GF Value™ of $163.77.
GuruFocus considers iRhythm Holdings to be Significantly Undervalued.
Key valuation signals for LTS:0A7L:
Scaled Net Operating Assets: 0.33
GF Value™: $163.77 vs. price of $115.18 (29.7% below fair value)
No single metric tells the full story. See the LTS:0A7L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
69GF Score
Get the complete analysis for LTS:0A7L
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0A7L has been successfully added to your 
